Research programme: fatty acid synthase inhibitors - GlaxoSmithKline

Drug Profile

Research programme: fatty acid synthase inhibitors - GlaxoSmithKline

Alternative Names: GSK 837149A

Latest Information Update: 06 Sep 2011

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Small molecules; Sulfonamides; Urea compounds
  • Mechanism of Action Fatty acid synthetase complex inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 28 Aug 2011 Early research is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top